abiraterone nanocrystalline
/ Jiangsu Hengrui Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
August 07, 2025
Prospective, Single-Arm Phase II Study Evaluating the Efficacy and Safety of Neoadjuvant Therapy with Docetaxel Combined with Abiraterone Nanocrystal in Locally Advanced Prostate Cancer
(ChiCTR)
- P2 | N=20 | Recruiting | Sponsor: Zhejiang Cancer Hospital; Zhejiang Cancer Hospital
New P2 trial • Genito-urinary Cancer • Oncology • Prostate Cancer • Solid Tumor
1 to 1
Of
1
Go to page
1